OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies
Catherine H. Marshall, Lukasz P. Gondek, Jun Luo, et al.
Cancer Research (2022) Vol. 82, Iss. 22, pp. 4107-4113
Open Access | Times Cited: 23

Showing 23 citing articles:

Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
M.F. Mosele, C. Benedikt Westphalen, A Stenzinger, et al.
Annals of Oncology (2024) Vol. 35, Iss. 7, pp. 588-606
Open Access | Times Cited: 54

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline
Nadine Tung, Charité Ricker, Hans Messersmith, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 21, pp. 2599-2615
Closed Access | Times Cited: 20

Clonal Hematopoiesis in Women With Breast Cancer
Christina Mayerhofer, Rachel A. Freedman, Heather A. Parsons, et al.
Journal of Clinical Oncology (2025)
Closed Access

Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer
Catherine H. Marshall, Lukasz P. Gondek, В. Даниэльс, et al.
The Prostate (2024) Vol. 84, Iss. 10, pp. 954-958
Closed Access | Times Cited: 4

ESMO Recommendations on clinical reporting of genomic test results for solid cancers
Joris van de Haar, Paul Roepman, Fabrice André, et al.
Annals of Oncology (2024) Vol. 35, Iss. 11, pp. 954-967
Open Access | Times Cited: 3

Clonal Hematopoiesis, Inflammation, and Hematologic Malignancy
Rashmi Kanagal‐Shamanna, David B. Beck, Katherine R. Calvo
Annual Review of Pathology Mechanisms of Disease (2023) Vol. 19, Iss. 1, pp. 479-506
Open Access | Times Cited: 10

The Emerging Role of Circulating Tumor DNA in Non-Colorectal Gastrointestinal Cancers
Michael S. Lee, Ahmed O. Kaseb, Shubham Pant
Clinical Cancer Research (2023) Vol. 29, Iss. 17, pp. 3267-3274
Closed Access | Times Cited: 8

Clonal Hematopoiesis Is Associated With Cardiomyopathy During Solid Tumor Therapy
Etienne Léveillé, Rachel Jaber Chehayeb, Carlos Matute-Martínez, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 4, pp. 605-607
Open Access | Times Cited: 1

Potential immunosuppressive clonal hematopoietic mutations in tumor infiltrating immune cells in breast invasive carcinoma
Ramu Anandakrishnan, Ian J. Zyvoloski, Lucas R. Zyvoloski, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3

Molecular and clinical aspects relevant for counseling individuals with clonal hematopoiesis of indeterminate potential
Anna Maria Cacic, Felicitas Schulz, Ulrich Germing, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3

Epigenetic Mechanisms in Hematologic Aging and Premalignant Conditions
Bowen Yan, Qingchen Yuan, Olga A. Guryanova
Epigenomes (2023) Vol. 7, Iss. 4, pp. 32-32
Open Access | Times Cited: 2

Clonal hematopoiesis: a shared risk factor for cardiovascular diseases and tumors
Lingfeng Zha, Xiang Cheng
Oncology and Translational Medicine (2024) Vol. 10, Iss. 1, pp. 35-41
Open Access

Understanding the Landscape of Clinically Available Molecular Testing
Julia A. Elvin
Surgical Oncology Clinics of North America (2024) Vol. 33, Iss. 2, pp. 217-230
Closed Access

Utility of circulating tumor DNA in secondary liver malignancies: What we know and what is to come
Chase J. Wehrle, Noah X. Tocci, Keyue Sun, et al.
Journal of Surgical Oncology (2024)
Open Access

Circulating tumor DNA in management of primary liver malignancy: A review of the literature and future directions
Noah X. Tocci, Chase J. Wehrle, Keyue Sun, et al.
Journal of Surgical Oncology (2024)
Open Access

Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunity
Fumiaki Mukohara, Kazuma Iwata, Takamasa Ishino, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 35
Closed Access

The Most Disruptive Near-Term Use of AI in Cancer Care: Patient Empowerment Through Software Agents
Frank Austin Nothaft, Brad Power
AI in Precision Oncology (2024)
Closed Access

Detection and interpretation of clonal hematopoiesis variants during routine solid tumor next-generation sequencing: a single institution experience
Adil Menon, Madina Sukhanova, Kevin L Nocito, et al.
Journal of Molecular Diagnostics (2024) Vol. 26, Iss. 12, pp. 1149-1158
Open Access

Clonal hematopoiesis of indeterminate potential is a risk factor of gastric cancer: A Prospective Cohort in UK Biobank study
Zhihui Xi, Huolun Feng, Kunling Chen, et al.
Translational Oncology (2024) Vol. 52, pp. 102242-102242
Closed Access

Liquid biopsy for renal cell carcinoma: A comprehensive review of techniques, applications, and future prospects
Chinmay Jani, Nour Abdallah, Alan Tan, et al.
Kidney Cancer (2024) Vol. 8, Iss. 1, pp. 205-225
Open Access

Reduction of double-strand DNA break repair exacerbates vascular aging
Samuel I. Bloom, Jordan R. Tucker, Daniel R. Machin, et al.
Aging (2023) Vol. 15, Iss. 19, pp. 9913-9947
Open Access | Times Cited: 1

Potential immunosuppressive clonal hematopoietic mutations in tumor infiltrating immune cells in breast invasive carcinoma
Ramu Anandakrishnan, Ian J. Zyvoloski, Lucas R. Zyvoloski, et al.
Research Square (Research Square) (2022)
Open Access

Page 1

Scroll to top